BioSpace News Archive

Business

Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End

Mr. McEnany will Continue to Serve as Catalyst’s Non-Executive Chairman of the Board Following his Retirement Nationally Recognized Executive Recruitment Firm has been Retained to Initiate Search.

July 25, 2023
·
5 min read
Biotech Beach

Former Severe Fibromyalgia Patient Challenges Others to Empowerment with New Data Service

Thomasino Media shared that CEO Kristen Thomasino, a twenty-two time author, 2x CEO, and two time show host, has launched the Social Good Experiment to empower others who are facing similar struggles as she had to overcome.

July 25, 2023
·
2 min read
BioCapital

IMV announces the first wave of 2023 IMV ServiceTrak™ Clinical Laboratory Awardees at AACC 2023

Today IMV, part of Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the first wave of category winners of the 2023 IMV ServiceTrak™ Clinical Laboratory Awards.

July 25, 2023
·
2 min read
Biotech Bay

Fore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening Data

DNAnexus Inc. today announced that Fore Genomics, a proactive genetic testing company designed for healthy newborns, infants, and children, is using the DNAnexus platform for its FORESITE 360 test.

July 25, 2023
·
4 min read
Business

Baxter Announces Vantive as the Name of Proposed Kidney Care Spinoff

Baxter International Inc. today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses.

July 25, 2023
·
3 min read
Genetown

Merck is Safeguarding the Environment Through Green Chemistry

Many of us are trying to go green, changing our behavior and lifestyles to reduce our impact on the environment.

July 25, 2023
·
2 min read
Biotech Bay

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

Third Harmonic Bio, Inc. today announced its next-generation product candidate, THB335, a potent, highly selective oral small molecule KIT inhibitor with a meaningfully differentiated product profile as compared to the company’s first-generation product candidate THB001.

July 25, 2023
·
7 min read
Business

Halozyme To Report Second Quarter 2023 Financial and Operating Results

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its second quarter 2023 financial and operating results on Tuesday, August 8, 2023, following the close of trading.

July 25, 2023
·
2 min read
Biotech Bay

Mirum’s LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus in Patients with Alagille Syndrome

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that LIVMARLI® (maralixibat oral solution) has been authorized by Health Canada for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS).

July 25, 2023
·
9 min read
Business

Bryn Pharma Announces Expansion of Leadership Team as UTULY™ Investigative Needle-Free Epinephrine Nasal Spray Prepares for Market Entry

Bryn Pharma, LLC announced today that it has expanded its leadership team as the company further prepares for the market entry of UTULY™, an investigational self-administered form of epinephrine being studied for the treatment of type 1 allergic reactions, including anaphylaxis.

July 25, 2023
·
6 min read